Literature DB >> 25088834

Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.

Michele Gaeta1, Caterina Benedetto2, Fabio Minutoli1, Tommaso D'Angelo1, Ernesto Amato1, Silvio Mazziotti1, Santi Racchiusa1, Enricomaria Mormina1, Alfredo Blandino1, Stefano Pergolizzi1.   

Abstract

RATIONALE AND
OBJECTIVES: To investigate the value of diffusion-weighted (DW), perfusion-sensitive, and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) techniques in assessing the response of bone metastases from breast cancer to radiotherapy, with particular emphasis on the role of intravoxel incoherent motion (IVIM)-DW parameters as a potential valuable imaging marker of tumor response.
MATERIALS AND METHODS: Fifteen women having breast cancer and bone metastases underwent MRI before and after radiotherapy (3 weeks [time 1], 2 months [time 2], and 4 months [time 3]), consisting of DW, perfusion-sensitive (IVIM), and DCE acquisitions. MR-based DW and perfusion parameters, including water diffusivity (D), perfusion fraction (f), pseudodiffusion (D*), total apparent diffusion coefficient (ADC-total), fractionated ADCs (ADC-high and ADC-low), and initial area under the gadolinium concentration curve after the first 60 seconds (IAUGC60), were determined. The morphologic MRI findings were also recorded. A one-way repeated measures analysis of variance was used to compare the value of MR-based parameters at the different time points.
RESULTS: A significant variation between pretreatment (time 0) and post-treatment (times 1, 2, and 3) was found for ADC-total and D parameters (P < .001). A statistically significant reduction was also found for IAUGC60 values between times 0 and 3 (P < .001). A significant change across the different time points was observed for D* and IAUGC60 parameters (P < .001). On the contrary, there was no statistically significant change over time for parameters ADC-total, D, f, and IAUGC60 comparing response between each metastasis, that is, the response to therapy was similar for each metastasis.
CONCLUSIONS: DW, IVIM, and DCE-MRI techniques show effectiveness in assessing the response to radiotherapy in bone metastases from breast cancer.
Copyright © 2014 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DCE-MRI; DW; IVIM; bone metastases; radiotherapy

Mesh:

Substances:

Year:  2014        PMID: 25088834     DOI: 10.1016/j.acra.2014.05.021

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  20 in total

1.  Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions.

Authors:  Sunghoon Park; Kyu-Sung Kwack; Nam-Su Chung; Jinwoo Hwang; Hyun Young Lee; Jae Ho Kim
Journal:  Skeletal Radiol       Date:  2017-03-06       Impact factor: 2.199

2.  Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences.

Authors:  Theodoros Soldatos; Shivani Ahlawat; Elizabeth Montgomery; Majid Chalian; Michael A Jacobs; Laura M Fayad
Journal:  Radiology       Date:  2015-09-21       Impact factor: 11.105

3.  Optimization of intravoxel incoherent motion (IVIM): variability of parameters measurements using a reduced distribution of b values for breast tumors analysis.

Authors:  Natacha Raissa Doudou; Yajie Liu; Sylvanus Kampo; Kai Zhang; Yue Dai; Shaowu Wang
Journal:  MAGMA       Date:  2019-09-30       Impact factor: 2.310

Review 4.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

5.  Diffusion-weighted MRI with intravoxel incoherent motion modeling for assessment of muscle perfusion in the thigh during post-exercise hyperemia in younger and older adults.

Authors:  Fatemeh Adelnia; Michelle Shardell; Christopher M Bergeron; Kenneth W Fishbein; Richard G Spencer; Luigi Ferrucci; David A Reiter
Journal:  NMR Biomed       Date:  2019-03-12       Impact factor: 4.044

6.  Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.

Authors:  Michele Anzidei; Alessandro Napoli; Beatrice Sacconi; Fabrizio Boni; Vincenzo Noce; Michele Di Martino; Luca Saba; Carlo Catalano
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

Review 7.  Diffusion MRI in early cancer therapeutic response assessment.

Authors:  C J Galbán; B A Hoff; T L Chenevert; B D Ross
Journal:  NMR Biomed       Date:  2016-01-15       Impact factor: 4.044

8.  Effect of granulocyte colony-stimulating factor on bone marrow: evaluation by intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Fabio Minutoli; Stefano Pergolizzi; Alfredo Blandino; Enricomaria Mormina; Ernesto Amato; Michele Gaeta
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

9.  Comparison of 3T diffusion-weighted MRI and 18F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values.

Authors:  So-Yeon Lee; Won-Hee Jee; Ie Ryung Yoo; Joon-Yong Jung; Soo-A Im; Yang-Guk Chung; Jin Hyoung Kang
Journal:  Br J Radiol       Date:  2019-07-24       Impact factor: 3.039

Review 10.  The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

Authors:  William A Hall; Eric S Paulson; Uulke A van der Heide; Clifton D Fuller; B W Raaymakers; Jan J W Lagendijk; X Allen Li; David A Jaffray; Laura A Dawson; Beth Erickson; Marcel Verheij; Kevin J Harrington; Arjun Sahgal; Percy Lee; Parag J Parikh; Michael F Bassetti; Clifford G Robinson; Bruce D Minsky; Ananya Choudhury; Robert J H A Tersteeg; Christopher J Schultz
Journal:  Eur J Cancer       Date:  2019-10-12       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.